Patent details

Basic Information

Publication number:

EP3288980

PCT Application Number:

US2016029878

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167245125

PCT Publication Number:

WO2016176504

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY

French Title of Invention:

TRAITEMENT DU MÉLANOME PD-L1 POSITIF À L'AIDE D'UN ANTICORPS ANTI-PD-1

German Title of Invention:

BEHANDLUNG VON PD-L1-POSITIVEM MELANOM MIT EINEM ANTI-PD-1-ANTIKÖRPER

SPC Number:

Dates

Filing date:

28/04/2016

Grant date:

10/03/2021

EP Publication Date:

07/03/2018

PCT Publication Date:

03/11/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/03/2021

EP B1 Publication Date:

10/03/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/04/2021

Expiration date:

28/04/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/03/2021

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Inventor

Name:

YANG, Arvin

Address:

United States (US)

Priority

Priority Number:

201562153954 P

Priority Date:

28/04/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; A61P 35/00; C07K 16/28;

Publication

European Patent Bulletin

1

Issue number:

202110

Publication date:

10/03/2021

Description:

Grant (B1)

2

Issue number:

202202

Publication date:

12/01/2022

Description:

Opposition procedure started

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages